关键词: Chronic kidney disease Hearing loss Hemodialysis Tinnitus vertigo

来  源:   DOI:10.1007/s12070-024-04586-y   PDF(Pubmed)

Abstract:
UNASSIGNED: Exploring the auditory and vestibular manifestations associated with chronic kidney disease (CKD) has been growing in recent years. Understanding these complaints in CKD patients is crucial for comprehensive patient care. This review aimed to investigate the audiological findings and profiles across various stages of CKD and guide for informed decision-making in their management.
UNASSIGNED: Relevant articles from PubMed, ScienceDirect, EBSCO Medline, SCOPUS, Google Scholar, and Clinical Key were identified for review. The selected articles were published from 2008 to 2023 and written in English language. A total of 41 articles on auditory and vestibular assessments in CKD were eligible for review.
UNASSIGNED: Pure tone audiometry (PTA), immittance audiometry (IA) and otoacoustic emissions (OAEs) were the most commonly employed hearing tests respectively, with a higher frequency of utilization in hemodialysis cases compared to non-hemodialysis ones. Also, vestibular evoked myogenic potentials (VEMPs) emerged as the most popular vestibular test among hemodialysis patients while questionnaires were frequently employed in CKD patients. Moreover, our analysis suggests a potential association between the duration of hemodialysis and the development of tinnitus and vertigo. Abnormalities were also observed in auditory brainstem response (ABR), speech audiometry, central auditory processing tests and videonystagmography (VNG) assessment in hemodialysis and non-hemodialysis patients.
UNASSIGNED: CKD patients, particularly those undergoing hemodialysis, face a higher risk of hearing loss, tinnitus, and vestibular complaints. Performing otoacoustic emissions and vestibular-evoked myogenic potentials along with PTA on CKD patients, regardless of the disease stage is recommended to more effective management of audiovestibular complaints in these population.
摘要:
探索与慢性肾脏疾病(CKD)相关的听觉和前庭表现近年来一直在增长。了解CKD患者的这些抱怨对于全面的患者护理至关重要。这篇综述旨在调查CKD各个阶段的听力学发现和概况,并指导其管理中的明智决策。
来自PubMed的相关文章,ScienceDirect,EBSCOMedline,Scopus,谷歌学者,并确定了临床密钥进行审查。选定的文章于2008年至2023年发表,并用英语撰写。共有41篇关于CKD听觉和前庭评估的文章符合审查条件。
纯音测听(PTA),导纳测听法(IA)和耳声发射(OAE)分别是最常用的听力测试,与非血液透析相比,血液透析病例的使用率更高。此外,前庭诱发肌源性电位(VEMPs)是血液透析患者中最受欢迎的前庭检查,而CKD患者经常采用问卷调查。此外,我们的分析提示血液透析持续时间与耳鸣和眩晕的发生有潜在关联.在听觉脑干反应(ABR)中也观察到异常,言语测听,血液透析和非血液透析患者的中央听觉处理测试和视频眼震描记术(VNG)评估。
CKD患者,尤其是那些接受血液透析的人,面临更高的听力损失风险,耳鸣,和前庭抱怨。对CKD患者进行耳声发射和前庭诱发的肌源性电位以及PTA,无论疾病阶段如何,建议在这些人群中更有效地管理前庭主诉。
公众号